Mapping the history and current situation of research on John Cunningham virus – a bibliometric analysis by Zheng, Hua-chuan et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Infectious Diseases
Open Access Correspondence
Mapping the history and current situation of research on John 
Cunningham virus – a bibliometric analysis
Hua-chuan Zheng*1, Lei Yan2, Lei Cui2, Yi-fu Guan1 and Yasuo Takano3
Address: 1Department of Biochemistry and Molecular Biology, College of Basic Medicine, China Medical University, Shenyang, PR China, 
2Department of Medical Informatics and Information System, China Medical University, Shenyang, PR China and 3Department of Diagnostic 
Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
Email: Hua-chuan Zheng* - zheng_huachuan@hotmail.com; Lei Yan - yanlei1@hotmail.com; Lei Cui - zilu85@hotmail.com; Yi-
fu Guan - yfguan@mail.cmu.edu.cn; Yasuo Takano - ytakano@med.u-toyama.ac.jp
* Corresponding author    
Abstract
Background: John Cunningham virus (JCV) constitutes a family of polyoma viruses, which plays
important roles in the progressive multifocal leukoencephalopathy (PML) and tumorigenesis.
However, no bibliometric investigation has been reported to guide the researchers and potential
readers.
Methods: Papers were collected from database Sci-expanded and Pubmed until May 22, 2008. The
highly-productive authors, institutes and countries, highly-cited authors and journals were ranked.
The highly-cited articles were subjected to co-citation and chronological analysis with highly-
frequent MeSH words for co-occurrence analysis.
Results: Until now, 1785 articles about JCV were indexed in Sci-expanded and 1506 in Pubmed.
The main document type was original article. USA, Japan and Italy were the largest three producers
about JCV. Temple University published 128 papers and ranked the top, followed by University of
Tokyo. Khalili K and Yogo Y became the core authors due to more than 20 documents produced.
Journal of Neurovirology published more than 15 papers and ranked the top. Padgett BL and Berger
JR were the first two highly-cited authors. Journal of Virology and Journal of Neurovirology
respectively ranked to the first two highly-cited journals. These top highly-cited articles were
divided into 5 aspects: (1) The correlation between JC virus and tumors; (2) Causal correlation of
JCV with PML; (3) Polyoma virus infection and its related diseases in renal-allograft recipients; (4)
Detection of JCV antibody, oncogene and its encoding protein; (5) Genetics and molecular biology
of JCV. The MeSH/subheadings were classified into five groups: (1) JCV and virus infectious
diseases; (2) JCV pathogenicity and pathological appearance of PML; (3) JCV isolation and detection;
(4) Immunology of JCV and PML; (5) JCV genetics and tumors.
Conclusion:  JCV investigation mainly focused on its isolation and detection, as well as its
correlation with PML and tumors. Establishment of transgenic animal model using JCV T antigen
would be a hopeful and useful project in the further study.
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Background
John Cunningham virus (JCV) constitutes a family of
polyoma viruses, which contain small, circular and dou-
ble-stranded DNA genomes. The early region is alterna-
tively spliced to produce large T antigen and small t antigen
[1]. T antigen, a large nuclear phosphoprotein for viral
DNA replication, binds to viral replication region to pro-
mote the unwinding of double helix and recruitment of
cell proteins that are required for DNA synthesis. The late
region encodes the capsid structural protein VP1, VP2 and
VP3 due to alternative splicing and the small regulatory
protein known as agnoprotein [1,2]. VP proteins are
essential to assemble with viral DNA to form virons. Sero-
logical studies have indicated an asymptomatic JCV infec-
tion in about 90% of the adult population, but it may be
activated under immunosuppressive conditions, leading
to the lethal demyelinating disease, progressive multifocal
leukoencephalopathy (PML) [1-5]. Evidences from trans-
genic and infectious animal models indicated that JCV
could transform cells and cause various malignancies [6-
9]. In recent years, links have been suggested between JCV
and various types of human cancers, including colorectal,
prostate and esophageal cancers, brain tumors, bronchop-
ulmonary carcinoma and B cell lymphoma [1-9], pointing
out its roles as oncovirus. However, no bibliometric inves-
tigation has been reported to guide the researchers and
potential readers.
Investigators in some fields commonly predict that deci-
sion making for the following experiments, clinical prac-
tice and paper's submission should be based on the
findings of scientific studies published in journals.
Although scientific papers have provided useful and help-
ful information to the readers, it is a little difficult to learn
about the history, status and future trend of some study
field. The bibliometric method employs empiric data and
quantitative analysis to trace the core production or cita-
tion, the content or quality of publications, and motiva-
tions of the researchers in the form of published literature
so that it proves to be a valid and reliable way to map
external and internal features of a scientific field [10]. A
key assumption underpinning this method to catch
insight into the flow of knowledge is that investigation
papers represent knowledge produced by scientific
research. Generally, academic productivity of individuals
or groups is measured by counting the number of publi-
cations. The number of times that one work is cited is
viewed as a measure of research impact. That is, the more
frequently a paper is cited, the higher its impact or quality
[10,11]. Examination of bibliometric information shows
the communication patterns of the investigation within
the field and the patterns of influence among different
work. Authors who publish earlier and experience fre-
quent citations tend to accrue the number of citations
over time as Matthew effect describes. For example, co-
citation analysis (in which two papers are cited together in
a paper) can indicate a strong conceptual relationship
between the studies. On the other hand, PubMed indexes
journal articles using MeSH terms, which constitute a the-
saurus that embodies all the concepts appearing in the
medical literature and are arranged in a hierarchical, tree-
like structure by subject categories. Associated with MeSH
is a list of corresponding subheadings to enhance the
focus of MeSH searches. The combination of MeSH terms
and subheadings can not only facilitate the sensitivity and
specificity of search, but also indicate the research con-
tents and the relationship between papers [12-14]. If the
further co-occurrence cluster analysis of MeSH is applied
in some field, the close link between subtrees of the field
will be well established.
In the present study, production and citation of JCV
research have been analyzed using such bibliometric
methods as chronological, co-citation and co-occurrence
analysis to explore the whole history, current status and
frontier about JCV study.
Methods
Data collection
The bibliographic data were collected in the database of
the Institute for Scientific Information available on the
web (http://www.isiknowledge.com, Sci-expanded) and
National Library of Medicine on the web (http://
www.ncbi.nlm.nih.gov/sites/entrez, Pubmed) until May
22, 2008. The tile, author, address, source, references or
the US list of the papers were downloaded according to
the retrieval strategy of "JC virus OR John Cunningham
virus OR JCV OR JC polyomavirus OR JC polyoma virus"
for Sci-expanded or Pubmed.
Highly-produced and -cited analysis
Using Foxpro 5.0, Microsoft Excel, Bibliographic Item Co-
occurrence Mining System (BIOCOMS) provided by Cui
Lei and Sci-expanded statistical system, we applied Sci-
expanded data to determine the document types, core
authors, highly-produced institutes and countries. The ref-
erences were analyzed to clarify the distribution of highly-
cited papers, authors and journals. The top MeSH/sub-
heading words were collected from Pubmed and sub-
jected to statistical analysis for highly-frequent ones.
Cluster analysis
After their identification, the top 34 most-cited articles
were subjected to co-citation cluster analysis according to
their co-citation times in one paper. The 48 highly-fre-
quent MeSH/subheadings of all articles from Pubmed
were studied using co-occurrence cluster analysis in term
of their co-existence times in one paper. In any cluster
analysis, the matrixes were built up according to co-cita-
tion or -occurrence times between the selected articles orBMC Infectious Diseases 2009, 9:28 http://www.biomedcentral.com/1471-2334/9/28
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words. Then, the related matrixes were developed using
Ochiai index as previously described [15-18]. Finally, we
employed the SPSS 10.0 software to perform the cluster
analysis of these related matrixes.
Results
Core countries, institutes, authors and journals
Until May 22, 2008, 1785 articles about JCV were indexed
in Sci-expanded with 62508 references and 1506(225
reviews) in Pubmed with 6435 major MeSH/subheading
words. The literature about JCV was gradually rising from
3 articles in 1976 until 179 in 2006 as indicated in Figure
1. The average annual growth rate was 5.7 pieces in the
period. According to document type, there were 1307
original articles (73.2%), 123 reviews (6.9%) and 209
meeting abstracts (11.7%) in all collected literature (Table
1). In overall 21 countries listed, USA, Japan, Italy and
Germany were in order the largest four producers about
JCV despite 62 countries included (Table 2). The overall
1245 institutes were mentioned to investigate JCV, among
which Temple University of USA published 128 papers
and ranked the top, followed by University of Tokyo, and
National Institute of Neurological Disorder and Stroke
subsequently. Fourteen of 21 (66.7%) core institutes
come from USA with three core institutes in Italy (Table
3). Such 33 authors as Khalili K, Yogo Y and etc produced
more than 20 documents in spite of all 4856 authors
involved. There were 9 highly-produced scientists from
Temple University and 6 from University of Tokyo, Japan,
and 4 from National Institute of Neurological Disorder
and Stroke, USA respectively (Table 4). As shown in Table
5, Journal of Neurovirology, Journal of Virology, Virology,
Journal of Medical Virology, Journal of General Virology
and so forth published more than 15 papers and were
considered as the core journals although there existed JCV
papers in 395 journals. These source journals mainly
include the field of Virology, Neurosciences, Clinical Neu-
rology, Immunology, Pathology, Oncology and so on
(Table 6).
Highly-cited authors, journals and papers
The papers of 10 highly-cited authors (totally 1577 pro-
ducers) like Padgett BL and Berger JR were cited for more
than 400 times, among whom 8 persons come from USA
(Table 7). The 10 highly-cited journals (totally 3584 jour-
nals) were selected due to more than 1179 citation times,
including 3 for Virology and 4 for comprehensive journals
(Table 8). Journal of Virology and Journal of Neurovirol-
ogy respectively ranked to the first two among 404 cited
journals (Table 9). The highly-cited papers were chrono-
logically analyzed and grouped into two stages: (1) 1971–
1984: discovery and isolation of JCV in PML disease and
(2) 1985-present: clarification of JCV genomic DNA
sequence and its correlation with diseases (Table 9).
Co-citation analysis of highly-cited articles
In the overall references about JCV, most highly-cited arti-
cles were published before 1999 with more than 90 cita-
tion times and came from major journals, such as Journal
of Infectious Disease, Journal of Virology, Science, New
Temporal distribution of production about JCV investigation Figure 1
Temporal distribution of production about JCV investigation.
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England Journal of Medicine and so forth. As shown in
Figure 2, these top highly-cited articles were divided into
5 aspects by co-citation analysis: (1) The correlation
between JC virus and tumors; (2) Causal correlation of
JCV with PML: pathogenesis and molecular biology; (3)
Polyoma virus infection and its related diseases in renal-
allograft recipients; (4) Detection of JCV antibody, gene
and encoding protein; (5) Genetics and molecular biol-
ogy of JCV.
Co-occurrence analysis of highly-frequent MeSH/
subheading words
The 48 highly-frequent MeSH/subheading words gener-
ally existed for more than 25 times in the papers about
JCV (Table 10). Among them, 17 words (35.4%)
belonged to the C02 subcategory of MeSH (Viral Disease)
and 15 (31.3%) to B04 subcategory (Viruses). These
MeSH/subheadings were classified into five groups: (1)
JCV and virus infectious diseases; (2) JCV pathogenicity
and pathological appearance of PML; (3) JCV isolation
and detection; (4) Immunology of JCV and PML; (5) JCV
genetics and tumors(Figure 3).
Discussion
A systematic view of JCV papers to discern the distinct set
of core researchers, institutional affiliations and corre-
sponding countries helps us to gain a deeper understand-
Table 3: The core institutes to investigate the JCV
Num Institution name Country Record count Percentage(%)
1 Temple University USA 128 7.2
2 University of Tokyo Japan 86 4.8
3 National Institute of Neurological and Communication Disorders and Stroke USA 79 4.4
4 Harvard University USA 61 3.4
5 Hokkaido University Japan 59 3.3
6 National Institute of Neurological Disorder and Stroke USA 56 3.1
7 Pennsylvania State University USA 56 3.1
8 Thomas Jefferson University USA 47 2.6
9 University of Milan Italy 40 2.2
10 University of Wisconsin USA 39 2.2
11 Brown University USA 38 2.1
12 Johns Hopkins University USA 36 2.0
13 National Cancer Institute USA 32 1.8
14 University of California san Diego USA 31 1.7
15 University of Wurzburg Germany 29 1.6
16 University of Pittsburgh USA 28 1.6
17 IRCCS Italy 25 1.4
18 Baylor College of Medicine USA 24 1.3
19 University of Hamburg Germany 24 1.3
20 National Institute of Health USA 23 1.3
21 University of Ferrara Italy 20 1.1
Table 1: Document types of the scientific papers about JCV
Num Document type Record count Percentage(%)
1 Original article 1307 73.2
2 Meeting abstract 209 11.7
3 Review 123 6.9
4N o t e 6 3 3 . 5
5 Letter 40 2.2
6 Editorial material 31 1.7
7 Correction 4 0.20
8 Book review 3 0.17
9 Discussion 2 0.11
Table 2: The territory distribution of the scientific papers about 
JCV
Num Country Record count Percentage(%)
1U S A 9 6 8 5 4 . 2
2 Japan 190 10.6
3 Italy 173 9.7
4G e r m a n y 1 5 8 8 . 8
5U K 8 8 5 . 0
6F r a n c e 7 2 4 . 0
7 Spain 48 2.7
8 Switzerland 44 2.5
9 Canada 37 2.1
10 Sweden 36 2.0
11 Taiwan 24 1.3
12 Norway 22 1.2
13 China 15 0.8
14 Australia 14 0.8
15 Poland 13 0.7
16 Belgium 12 0.7
17 Brazil 12 0.7
18 South Korea 12 0.7
19 Lithuania 11 0.6
20 Finland 10 0.6
21 Netherlands 10 0.6BMC Infectious Diseases 2009, 9:28 http://www.biomedcentral.com/1471-2334/9/28
Page 5 of 12
(page number not for citation purposes)
ing of approaches to JCV. As shown in our bibliometric
analysis, the document type of JCV was original articles
(1307/1785) and many data (209/1785) had been com-
municated in meeting activities. The review part occupies
6.9% (123/1785). The results indicated that JCV research
was very active and interesting many investigators, and
some scientists had begun to summary the achievement of
JCV. Among 33 core authors, 19 persons come from Tem-
ple University, University of Tokyo, and National Institute
of Neurological Disorder and Stroke, which ranked the
top in the highly-produced institutes. Additionally, 14
(66.7%) core institutes of USA also focused on the inves-
tigation of JCV and USA was the first top producer of JCV
papers until now. JVC was discovered in 1971 by Ameri-
can Padgett and named after the two initials of a patient
with progressive multifocal leukoencephalopathy (PML).
It was suggested that the JCV investigation originated
from USA, which consequently became the top source
information for JCV. It is rational and helpful for the sci-
entists to tack the core authors and institutes to grasp the
frontier of this field, open new projects and submit their
distinguished work.
The list of top-cited articles about JCV identified the
authors, articles and topics that reflected history and
development of this specialty. Among highly-cited
authors, Padgett is the discoverer for JCV in PML and pub-
lished the first article in Lancet. The paper has been cited
for 366 times and ranks the top in the highly-cited ones.
His outstanding was also due to another article in Journal
of Infectious disease, which described the detection of the
antibody against JCV in PML. Therefore, it is explanatory
for Padgett BL to be the most highly cited. These top-cited
articles produced valuable information for readers, but
also tell us some historical achievement in some field.
According to these highly-cited papers, the research about
JCV was chronologically separated into beginning and
developing stages including discovery and isolation of
JCV in PML disease, and clarification of JCV genomic DNA
sequence and its relationship with diseases by polymerase
chain reaction (PCR) respectively.
Table 4: The core authors for JCV investigation
Num Core author Institutes Record count Percentage(%)
1 Khalili K Temple University, USA 174 9.8
2 Yogo Y University of Tokyo, Japan 75 4.2
3 Major EO National Institute of Neurological Disorders and Stroke, USA 74 4.2
4 Stoner GL National Institute of Neurological Disorders and Stroke, USA 70 3.9
5 Del Valle L Temple University, USA 62 3.5
6 Kitamura T University of Tokyo, Japan 59 3.3
7 Nagashima K Hokkaido University, Japan 57 3.2
8 Frisque RJ Pennsylvania State University, USA 48 2.7
9 Ryschkewitsch CF National Institute of Neurological Disorders and Stroke, USA 45 2.5
10 Koralnik IJ Harvard Medical School, USA 43 2.4
11 Gordon J Temple University, USA 42 2.4
12 Sugimoto C University of Tokyo, Japan 41 2.3
13 Atwood WJ Brown University, USA 40 2.2
14 Walker DL University of Wisconsin Medical School, USA 39 2.2
15 Zheng HY University of Tokyo, Japan 37 2.1
16 Ferrante P University of Milan, Italy 33 1.9
17 Sawa H Hokkaido University, Japan 32 1.8
18 Agostini HT National Institute of Neurological Disorders and Stroke, USA 28 1.6
19 Boland CR Baylor University Medical Center, USA 27 1.5
20 Takasaka T University of Tokyo, Japan 26 1.5
21 White MK Temple University, USA 26 1.5
22 Croul S Temple University, USA 25 1.4
23 Safak M Temple University, USA 25 1.4
24 Wegner M Universität Hamburg, Germany 25 1.4
25 Amini S Temple University, USA 24 1.3
26 Padgett BL University of Wisconsin Medical School, USA 23 1.3
27 Reiss K Temple University, USA 22 1.2
28 Tanaka S Hokkaido University, Japan 22 1.2
29 Berger JR Temple University, USA 21 1.2
30 Butel JS Baylor University Medical Center, USA 21 1.2
31 Dorries K Universität Würzburg, Germany 21 1.2
32 Shah KV Johns Hopkins Bloomberg School of Public Health, USA 21 1.2
33 Ikegaya H University of Tokyo, Japan 20 1.1BMC Infectious Diseases 2009, 9:28 http://www.biomedcentral.com/1471-2334/9/28
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Table 6: Subject categories for JCV investigation
Num Subject category Record count Percentage (%)
1 Virology 601 33.7
2 Neurosciences 329 18.4
3 Clinical Neurology 238 13.3
4 Immunology 154 8.6
5 Pathology 154 8.6
6 Oncology 144 8.1
7 Biochemistry & Molecular Biology 142 8.0
8 Infectious Diseases 128 7.2
9 Biotechnology & Applied Microbiology 103 5.8
10 Cell Biology 85 4.8
11 Microbiology 80 4.5
12 Transplantation 80 4.5
13 Surgery 73 4.1
14 Genetics & Heredity 61 3.4
15 Medicine, Research & Experimental 60 3.4
16 Medicine, General & Internal 58 3.3
17 Evolutionary Biology 40 2.2
18 Hematology 35 2.0
19 Urology & Nephrology 34 1.9
20 Pediatrics 33 1.9
21 Biochemical Research Methods 32 1.8
22 Gastroenterology & Hepatology 31 1.7
23 Multidisciplinary Sciences 31 1.7
Table 5: Core journals of JCV investigation
Num Source title Record count Percentage(%)
1 Journal of Neurovirology 167 9.4
2 Journal of Virology 128 7.2
3 Virology 69 3.9
4 Journal of Medical Virology 51 2.9
5 Journal of General Virology 44 2.5
6 Annals of Neurology 36 2.0
7 Journal of Infectious Diseases 35 2.0
8 Journal of Clinical Micrology 31 1.7
9 Journal of Neuropathology and Experimental Neurology 31 1.7
10 AIDS 29 1.6
11 Journal of Biological Chemistry 29 1.6
12 Neurology 29 1.6
13 Oncogene 25 1.4
14 Proceedings of The National Academy of Sciences of The United States of America 25 1.4
15 Journal of Virological Methods 24 1.3
16 Transplantation 23 1.3
17 Gastroenterology 21 1.2
18 Anthropological Science 20 1.1
19 International Journal of Cancer 20 1.1
20 Polyomaviruses and Human Diseases 19 1.1
21 Archives of Virology 17 1.0
22 Clinical Infectious Diseases 16 0.9
23 American Journal of Transplantation 15 0.8
24 New England Journal of Medicine 15 0.8BMC Infectious Diseases 2009, 9:28 http://www.biomedcentral.com/1471-2334/9/28
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Most of highly-cited journals almost come from Virology,
Neurology, and comprehensive journals, indicating JCV
paper mainly absorbs frontier knowledge from these
fields. Oncogene, Journal of Biological Chemistry, and
International Journal of Cancer also become the highly-
cited journal (data not shown), indicating the attempts of
JCV study to combine with Molecular Biology and Oncol-
ogy. This data also demonstrate the close link of JCV with
these specialties. In the overall references of JCV papers,
most highly-cited articles were published in Proceeding of
National Academy and Science, USA and New England
Journal of Medicine, indicating that these famous-brand
journals highlight the investigation of JCV and empha-
sized the scientific achievement of JCV. Therefore, investi-
gators of JCV not only read the journals of Virology, but
also emphasized the novel findings of JCV published in
other journals with high impact factor.
Methodologically, the cluster techniques include text seg-
mentation, summary extraction, feature selection, term
association, cluster generation, topic identification, and
information mapping [19]. Clustering algorithms promi-
nently used in co-citation analysis has proved very useful
in revealing research streams in some discipline [20-23].
Here, we carried out empirical co-citation analysis to map
the network of highly-cited papers about JCV. Our data
indicated that these top highly-cited articles were grouped
into such 4 aspects as the correlation between JC virus and
tumors, causal correlation of JCV with PML, polyoma
virus infection and its related diseases in renal-allograft
recipients, detection of JCV antibody, oncogene and its
encoding protein, and genetics and molecular biology of
JCV. These findings might not only enrich the knowledge
of students and specialists about the development's his-
tory of JCV research, but also open new bursts of scientific
investigation.
Co-occurrence has been considered as carriers of meaning
across different domains in studies of science. Based on
this principle, we performed co-occurrence cluster analy-
sis using Pubmed MeSH/subheading words to construct a
new tie between two words depending on the co-existing
frequencies [24]. Consequently, most of the top highly-
frequent MeSH/subheading words are mainly classified
into C02 subcategory of MeSH (Viral Disease) and B04
subcategory (Viruses). The analytic data showed that the
contents of published papers about JCV included JCV iso-
lation and detection, as well as JCV and virus infectious
diseases like PML or tumors. It was suggested that JCV
investigation centered on its isolation, its pathogenicity of
Table 7: The highly-cited authors for JCV papers
Num Authors Institute CT CP(%)
1 Padgett BL University of Wisconsin Medical School, USA 958 1.53
2 Berger JR University of Kentucky, USA 761 2.75
3 Agostini HT National Institute of Neurological Disorders and Stroke, USA 649 3.79
4 Frisque RJ Pennsylvania State University, USA 630 4.80
5 Major EO National Institute of Neurological Disorders and Stroke, USA 604 5.77
6 Walker DL Tulane University, USA 495 6.56
7 Arthur RR Johns Hopkins University, USA 430 7.25
8 Dorries K University of Wurzburg, Germany 419 7.92
9 Yogo Y University of Tokyo, Japan 415 8.58
10 Shah KV Johns Hopkins University, USA 400 9.23
CT, cited time; CP, cumulative percentage
Table 8: The highly-cited journals for JCV papers
Num Journal CT CP(%)
1 Journal of Virology 5871 9.43
2 Virology 2498 13.44
3 Proceedings of The National Academy of Sciences of The United States of America 2313 17.16
4 Journal of Infectious Diseases 2230 20.74
5 New England Journal of Medicine 1655 23.40
6 Journal of Neurovirology 1274 25.45
7 Science 1230 27.42
8C e l l 1227 29.39
9 Journal of Clinical Microbiology 1201 31.32
10 Annals of Neurology 1179 33.22
CT, cited time; CP, cumulative percentageBMC Infectious Diseases 2009, 9:28 http://www.biomedcentral.com/1471-2334/9/28
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Table 9: The highly-cited articles for the JCV investigation
N Authors Year Title Source V P CT CP
1 Padgett BL 1971 Cultivation of papova-like virus from human brain with progressive 
multifocal leucoencephalopathy.
Lancet 1 1257 366 0.59
2 Frisque RJ 1984 Human polyomavirus JC virus genome. J Virol 51 458 360 1.16
3 Major EO 1992 Pathogenesis and molecular biology of progressive multifocal 
leukoencephalopathy, the JC virus-induced demyelinating disease of 
the human brain
Clin Microbiol Rev 5 49 285 1.62
4 Padgett BL 1973 Prevalence of antibodies in human sera against JC virus, an isolate 
from a case of progressive multifocal leukoencephalopathy
J Infect Dis 127 467 219 1.97
5 Chesters PM 1983 Persistence of DNA sequences of BK virus and JC virus in normal 
human tissues and in diseased tissues.
J Infect Dis 147 676 215 2.31
6 Berger JR 1987 Progressive multifocal leukoencephalopathy associated with human 
immunodeficiency virus infection. A review of the literature with a 
report of sixteen cases.
Ann Intern Med 107 78 197 2.63
7 Astrom KE 1958 Progressive multifocal leuko-encephalopathy; a hitherto unrecognized 
complication of chronic lymphatic leukaemia and Hodgkin's disease
Brain 81 93 179 2.91
8 Yogo Y 1990 Isolation of a possible archetypal JC virus DNA sequence from 
nonimmunocompromised individuals.
J Virol 64 3139 172 3.19
9 Gardner SD 1971 New human papovavirus (B.K.) isolated from urine after renal 
transplantation
Lancet 1 1253 165 3.45
10 Tornatore C 1992 Detection of JC virus DNA in peripheral lymphocytes from patients 
with and without progressive multifocal leukoencephalopathy
Ann Neurol 31 454 146 3.69
11 Kitamura T 1990 High incidence of urinary JC virus excretion in nonimmunosuppressed 
older patients.
J Infect Dis 161 1128 136 3.90
12 Houff SA 1988 Involvement of JC virus-infected mononuclear cells from the bone 
marrow and spleen in the pathogenesis of progressive multifocal 
leukoencephalopathy.
New Engl J Med 318 301 135 4.12
13 Berger JR 1995 Progressive multifocal leukoencephalopathy: the evolution of a 
disease once considered rare
J Neurovirol 1 5 134 4.33
14 Arthur RR 1989 Detection of BK virus and JC virus in urine and brain tissue by the 
polymerase chain reaction.
J Clin Microbiol 27 1174 132 4.55
15 Walker DL 1973 Human papovavirus (JC): induction of brain tumors in hamsters Science 181 674 128 4.75
16 Loeber G 1988 DNA rearrangements in organ-specific variants of polyomavirus JC 
strain GS
J Virol 62 1730 126 4.95
17 White FA 1992 JC virus DNA is present in many human brain samples from patients 
without progressive multifocal leukoencephalopathy
J Virol 66 5726 117 5.14
18 Agostini HT 1996 Genotype profile of human polyomavirus JC excreted in urine of 
immunocompetent individuals.
J Clin Microbiol 34 159 114 5.32
19 Bergsagel DJ 1992 DNA sequences similar to those of simian virus 40 in ependymomas 
and choroid plexus tumors of childhood
New Engl J Med 326 988 108 5.49
20 Brooks BR 1984 Progressive multifocal leukoencephalopathy Neurol Clin 2 299 108 5.67
21 Markowitz RB 1993 Incidence of BK virus and JC virus viruria in human immunodeficiency 
virus-infected and -uninfected subjects.
J Infect Dis 167 13 108 5.84
22 Kenney S 1984 Prospective study of the human polyomaviruses BK and JC and 
cytomegalovirus in renal transplant recipients.
Science 226 1337 107 6.01
23 London WT 1978 Brain tumors in owl monkeys inoculated with a human polyomavirus 
(JC virus).
Science 201 1246 106 6.18
24 Coleman DV 1980 A prospective study of human polyomavirus infection in pregnancy J Infect Dis 142 1 105 6.35
25 Dorries K 1994 Infection of human polyomaviruses JC and BK in peripheral blood 
leukocytes from immunocompetent individuals.
Virology 198 59 105 6.52
26 Gardner SD 1984 Prospective study of polyomavirus type BK replication and 
nephropathy in renal-transplant recipients
J Clin Pathol 37 578 104 6.68
27 Flaegstad T 1991 Amplification and sequencing of the control regions of BK and JC 
virus from human urine by polymerase chain reaction
Virology 180 553 102 6.85
28 Hogan TF 1980 Human polyomavirus infections with JC virus and BK virus in renal 
transplant patients
Ann Intern Med 92 373 101 7.01
29 Martin JD 1985 Differences in regulatory sequences of naturally occurring JC virus 
variants
J Virol 53 306 97 7.16
30 Monaco MCG 1996 JC virus infection of hematopoietic progenitor cells, primary B 
lymphocytes, and tonsillar stromal cells: implications for viral latency.
J Virol 70 7004 96 7.32
31 Richardson EP 1961 Progressive multifocal leukoencephalopathy New Engl J Med 265 815 95 7.47
32 Randhawa PS 1999 Human polyoma virus-associated interstitial nephritis in the allograft 
kidney.
Transplantation 67 103 92 7.62BMC Infectious Diseases 2009, 9:28 http://www.biomedcentral.com/1471-2334/9/28
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PML and its genetics at early time. Recently, the causal
relationship between JCV and tumors has been empha-
sized by the scientists. It was demonstrated that JCV inves-
tigation like isolation and detection mainly aimed to
clarify the molecular mechanism of its relevant diseases
including PML and tumors.
As well known, JCV infection experiences two outcomes
as other viruses. In un-permissive condition, JCV infection
initiates binding to the JCV-sensitive cell surface and JCV
capsids undergo endocytosis and are transported to the
nucleus where the viral DNA is uncoated and the early
and late region begins to be transcripted. Subsequently,
JCV genomic DNA is assembled with caspid protein to
undergo the lytic viral release, finally to cause demyelinat-
ing disease, PML. Under permissive infection, viral DNA
can replicate, resulting in lytic infection with viral ampli-
fication and non-permissive cells don't allow the viral rep-
lication, leading to an abortive infection or cell
transformation [6-9]. The evidence provided enough rea-
sons for the following data: (1) The core and highly-cited
journals mainly contained the field of virology, neurology
and oncology; (2) The highly-cited articles and highly-fre-
quent MeSH/subheading also mentioned the research
contents of JCV, PML and tumors.
Recently, the further clarification of JCV genetics pro-
moted the scientists to detect its genomic existence in
tumors or make the transgenic mice to study the onco-
genic role of JCV. Our group had examined the JCV target-
ing T antigen using nested-PCR, real-time PCR, in situ
PCR, in situ hybridization, and immunohistochemistry
[6-9]. It was found that positive rate and copies of JCV
were higher in gastric, lung and tongue carcinomas than
corresponding normal tissues, indicating its oncogenic
role in epithelial carcinogenesis. Furthermore, JCV T anti-
gen can serve as helicase, and polymerase, orchestrate the
assembly and function of cellular proteins, disrupt the sig-
33 Frisque RJ 1992 The molecular biology of JC virus, causative agent of progressive 
multifocal leukoenchephalpathy
Mol Neurovirology 25 92 7.76
34 Padgett BL 1977 JC virus, a human polyomavirus associated with progressive multifocal 
leukoencephalopathy: additional biological characteristics and 
antigenic relationships
Infect Immun 15 656 90 7.91
V, volume; P, page; CT, cited times; CP, cumulative percentage
Table 9: The highly-cited articles for the JCV investigation (Continued)
Co-citation cluster analysis of highly-cited references Figure 2
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Co-occurrence cluster analysis of the highly-frequent MeSH/subheading words Figure 3
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Table 10: The highly-frequent MeSH/subheading words
Num MeSH/subheading words Subcategory number Times CP
1 JC Virus/Genetics B04.280.640.615.400 289 4.49
2 JC Virus/Isolation and Purification B04.280.640.615.400 216 7.84
3 Leukoencephalopathy, Progressive Multifocal/Virology C02.182.500.300.500 115 9.63
4 Leukoencephalopathy, Progressive Multifocal/Diagnosis C02.182.500.300.500 86 10.96
5 JC Virus/Physiology B04.280.640.615.400 84 12.27
6 JC Virus/Immunology B04.280.640.615.400 73 13.40
7 Polyomavirus/Genetics B04.280.640.615 69 14.47
8 Leukoencephalopathy, Progressive Multifocal/Pathology C02.182.500.300.500 68 15.53
9 BK Virus/Isolation and Purification B04.280.640.615.100 68 16.58
10 DNA, Viral/Analysis D13.444.308.568 64 17.57
11 Leukoencephalopathy, Progressive Multifocal/Drug Therapy C02.182.500.300.500 58 18.48
12 JC Virus/Pathogenicity B04.280.640.615.400 56 19.34
13 Tumor Virus Infections/Virology C02.928 54 20.18
14 Polyomavirus Infections/Virology C02.256.721 51 20.98
15 Leukoencephalopathy, Progressive Multifocal/Etiology C02.182.500.300.500 50 21.75
16 BK Virus/Genetics B04.280.640.615.100 50 22.53
17 Leukoencephalopathy, Progressive Multifocal/Microbiology C02.182.500.300.500 47 23.26
18 Leukoencephalopathy, Progressive Multifocal/Complications C02.182.500.300.500 45 23.96
19 JC Virus B04.280.640.615.400 45 24.65
20 Polyomavirus/Isolation and Purification B04.280.640.615 42 25.31
21 Acquired Immunodeficiency Syndrome/Complications C02.782.815.616.400.040 39 25.91
22 Polyomaviridae B04.280.640 38 26.50
23 DNA, Viral/Genetics D13.444.308.568 37 27.08
24 HIV Infections/Complications C02.782.815.616.400 36 27.64
25 Gene Expression Regulation, Viral G05.315.385 35 28.18
26 Polymerase Chain Reaction/Methods E05.393.620.500 34 28.71
27 Polyomavirus/Immunology B04.280.640.615 34 29.23
28 Leukoencephalopathy, Progressive Multifocal/Immunology C02.182.500.300.500 34 29.76
29 Tumor Virus Infections/Diagnosis C02.928 33 30.27
30 Tumor Virus Infections/Complications C02.928 33 30.79
31 Brain/Virology A08.186.211 33 31.30
32 Capsid Proteins D12.776.964.970.600.550 33 31.81
33 Brain/Pathology A08.186.211 31 32.29
34 Promoter Regions (Genetics) G06.184.603.080.689.675 31 32.77
35 Genes, Viral G14.330.605 30 33.24
36 JC Virus/Metabolism B04.280.640.615.400 30 33.71
37 Virus Replication G04.185.515.880.941 29 34.16
38 Polyomavirus Infections/Complications C02.256.721 28 34.59
39 DNA, Viral/Cerebrospinal Fluid D13.444.308.568 28 35.03
40 Neuroglia/Virology A08.637 28 35.46
41 Brain Neoplasms/Virology C04.588.614.250.195 27 35.88
42 AIDS-Related Opportunistic Infections/Drug Therapy C01.539.597.050 27 36.30
43 Tumor Virus Infections/Microbiology C02.928 27 36.72
44 Simian virus 40/Isolation and Purification B04.280.640.615.700 27 37.14
45 Brain/Microbiology A08.186.211 25 37.53
46 Kidney Transplantation E02.870.500 25 37.91
47 Polyomavirus Infections/Diagnosis C02.256.721 25 38.30
48 BK Virus/Immunology B04.280.640.615.100 25 38.69
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nal pathways of p53, Rb and Wnt signaling pathway, and
should be considered as a viral oncogene [2-4]. Therefore,
we are establishing a transgenic model of gastric neoplasia
induced by JCV T antigen, which will help to verify the
oncogenic role of JCV in gastric carcinoma and provide a
novel tool to investigate gastric carcinomas. It was
hypothesized that application of JCV T antigen in tumor
transgenic animal model would be a novel and hot
project in the future.
Conclusion
In this study, we successfully performed the scientometric
analysis of JCV literature. Our data indicated that JCV
mainly centered on PML and tumors. The bibliometric
study assists researchers to know the history and frontier
of JCV investigation, guide them to open new projects and
submit the distinguished work. These cluster methods
employed in this investigation can clarify the history, sta-
tus and development in the field of JCV.
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